Vividhmargi Trust has pledged 2,53,17,620 equity shares, representing 27.49% of the total paid-up equity share capital of Themis Medicare Limited . The shares were pledged on June 29, 2026, in favor of CTL Trusteeship Limited, acting as the Debenture Trustee for the lender Kotak Credit Opportunities Fund Trust. The disclosure was submitted to BSE Limited and National Stock Exchange of India Limited on July 3, 2026, under Regulation 31 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The encumbrance was created pursuant to a Debenture Trust Deed involving OSS Software Solutions Labs Private Limited as the issuer of unrated, unlisted, secured, redeemable non-convertible debentures. The borrowed amount of ₹135,00,00,000 will be utilized for personal use by the promoters and Persons Acting in Concert (PACs). The debt instrument does not currently have an ISIN allotted.

Details of the Encumbrance

The pledged shares are held in the name of three trustees of the Vividhmargi Trust: Mr. Dinesh Shantilal Patel, Mrs. Jayshree Dinesh Patel, and Dr. Sachin Dinesh Patel. The total promoter shareholding in Themis Medicare Limited stands at 6,18,03,990 equity shares, with the encumbered shares constituting 40.96% of the total promoter holding.

The filing confirms that the encumbrance is not related to the benefit of the listed company. The disclosure was signed by Dinesh Shantilal Patel, Trustee of Vividhmargi Trust, on July 21, 2026.

Vividhmargi Trust has pledged 2,53,17,620 equity shares, representing 27.49% of the total paid-up capital, of Themis Medicare Ltd in favor of CTL Trusteeship Limited. The encumbrance was established on June 29, 2026, to secure unrated, unlisted, secured, redeemable non-convertible debentures issued by OSS Software Solutions Labs Private Limited. The disclosure was submitted to the stock exchanges on July 3, 2026, under Regulation 31 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The pledged shares, valued at ₹284,19,02,845 based on a price of ₹112.25 per share, secure a debt amount of ₹135,00,00,000. The ratio of the value of shares to the amount involved is 1:2.10. The debenture trust deed governing this arrangement was entered into on June 25, 2026, between OSS Software Solutions Labs Private Limited as the issuer and CTL Trusteeship Limited as the debenture trustee. The borrowed funds are intended for personal use by the promoters and PACs.

Details of the Encumbrance

The disclosure specifies that the acquisition is treated as such under the takeover regulations due to the creation of an encumbrance. CTL Trusteeship Limited, acting in its capacity as the debenture trustee, now holds rights over the pledged shares. The acquirer clarified that it does not belong to the promoter or promoter group of the target company.

Capital Structure

The total equity share capital of Themis Medicare Limited remains unchanged at INR 9,21,00,120, comprising 9,21,00,120 fully paid-up equity shares of INR 1 each. The total diluted share and voting capital also stands at 9,21,00,120 shares. The aggregate holding of CTL Trusteeship Limited by way of encumbrance constitutes 27.49% of the total share capital as well as the total diluted share and voting capital of the company. The total promoter shareholding in the listed company is 6,18,03,990 equity shares, with the encumbered shares representing 40.96% of the promoter shareholding.